IFN-␥ Promotes Fas Ligand-and Perforin-Mediated Liver Cell Destruction by Cytotoxic CD8 T Cells

I
t is now well established that the activation state of APC determines whether interaction of T cells with Ag leads to tolerance induction or to proliferation and acquisition of effector cell function (1) (2) (3) (4) (5) (6) . In an autoimmune setting, stimulation of self-reactive CD8 T cells by activated APC could result in CTLmediated tissue destruction (7, 8) . To study these processes in an in vivo model, we have established a transfer system with CD8 T cells from P14 TCR transgenic (tg) 3 mice specific for the gp33 epitope of lymphocytic choriomeningitis virus (LCMV) and H8 tg recipient mice ubiquitously expressing gp33 (9) . After adoptive transfer into H8 mice, P14 T cells were tolerized rapidly by peripheral deletion and induction of anergy. However, bacterial and viral infections interfered with tolerance induction and led to CTLmediated immunopathology. Moreover, CD40 ligation of APC by agonistic mAb could mimic these inflammatory processes and induced vigorous expansion of adoptively transferred P14 T cells in H8 tg mice, which caused CTL-mediated liver cell destruction (10) . CTL are thought to destroy their target cells primarily through granule exocytosis, which requires perforin to facilitate entry of granzymes into the cytosol (11, 12) , and through the Fas ligand (FasL)/Fas pathway (13) (14) (15) . The inflammatory cytokine IFN-␥ represents an additional effector molecule released by activated CTL. In this study, we have used the P14/H8 transfer model described above to analyze the role of FasL, perforin, and IFN-␥ in liver cell destruction by self-reactive CTL in vivo.
Materials and Methods
Mice
C57BL/6 (B6) mice were obtained from our breeding colony and from Harlan Winkelmann (Borchen, Germany). P14 TCR-tg mice (line 318) specific for aa 33-41 (ϭ gp33 epitope) of the LCMV glycoprotein (16) and H8 tg mice ubiquitously expressing the LCMV gp33 epitope as a transgene (9) have been described previously. P14 mice deficient in Fas, FasL, perforin, or IFN-␥ were generated by breeding P14 mice with B6.Fas°(17) (M. Simon, MPI, Freiburg, Germany), B6.gld/gld (H. Eibel, University of Freiburg), B6.PKO (18) (M. Simon, MPI, Freiburg, Germany), or B6.IFN-␥°(19) (M. Kopf, ETH, Zürch, Switzerland) mice, respectively. Fas-deficient H8 tg mice were generated by breeding H8 tg mice with B6.Fas°mice (17) . P14 mice used in this study had been backcrossed eight times to B6, B6.Fas°, and B6.PKO mice were originally made on a B6 background using B6 embryonal stem cells. B6.IFN-␥°mice, originally made on a mixed 126/B6 background, had been backcrossed six times to B6.P14.Fas°, and P14.gld mice were used at 8 -10 wk of age. At this age, the mice had not yet developed lymphadenopathy; the frequency of doublenegative T cells in lymph node and spleen was below 5%; and all P14 T cells exhibited a naive phenotype (CD62L high , CD25 low , CD44 low ). All other mice, female or male, were used at 8 -16 wk of age. Mice were bred and kept in a conventional animal house facility. (20) . Abs were given on the day of cell transfer and 2 days afterward.
Adoptive cell transfers and anti-CD40 Ab treatment
Disease score
Illness of the mice was scored using the following scale: 0 ϭ healthy; 1 ϭ slightly ruffled fur; 2 ϭ ruffled fur, but active; 3 ϭ ruffled fur and inactive; 4 ϭ ruffled fur, inactive, and hunched; 5 ϭ moribund. Mice illness scores were monitored 1 wk after cell transfer.
used: anti-CD8 (clone 53-6.7), anti-CD44 (clone IM7), anti-CD62L (clone MEL-14), anti-TCR V␣2 (clone B20.1), anti-TCR V␤8 (clone MR5-2), anti-Fas (clone Jo2), and anti-FasL (clone MFL3). FasL staining of hepatic lymphocytes was performed after 4-h stimulation with 10 g/ml platebound anti-CD3 mAb (clone 17A2) and 20 M metalloproteinase inhibitor TAPI-1 (Calbiochem-Merck, Darmstadt, Germany) to avoid the cleavage of FasL from the cell surface. All Abs were purchased from BD PharMingen (San Diego, CA). The mAbs were directly labeled with FITC, PE, or APC, or were biotinylated. For the latter, APC-streptavidin (BD PharMingen) was used as a secondary reagent for detection. Before analysis of PBL, RBC were lysed using FACS lysing solution (BD PharMingen). Cells were analyzed on a FACSort flow cytometer (BD Biosciences, Mountain View, CA) using CellQuestPro software.
Preparation of hepatocytes and hepatic lymphocytes
Hepatocytes were prepared, as described in detail elsewhere (21) , with slight modifications. Briefly, mice were anesthetized and the peritoneal cavity was opened. The inferior vena cava was cannulated with a 0.45 ϫ 25-mm needle (Sterican, Braun, Melsungen) in the area of the lower abdomen, and perfusion was started. After a few seconds, the portal vein was sectioned. The liver was perfused sequentially with 5 ml HBSS without Ca 2ϩ and Mg 2ϩ (Biochrom, Berlin, Germany), containing 1% w/v glucose and 0.5 mM EGTA, followed by 10 ml collagenase solution (HBSS, containing 1% w/v glucose, 5 mM CaCl 2 , and 0.1 mg/ml liberase blendzyme 3 (Roche Diagnostics, Mannheim, Germany)). The liver was removed and filtered through a sterile 100-m nylon cell strainer (BD Biosciences). The cells were washed twice by centrifugation at 50 ϫ g for 2 min and resuspended in IMDM containing 10% FCS. Flow cytometry analysis of hepatocytes was performed, as described by Kaulek et al. (22) . A detector value of E-01 was used, and gating was performed with a logarithmic amplification for forward scatter and a linear amplification for side scatter. With these parameters, all different cell populations were obtained in the same plot.
To isolate hepatic lymphocytes, liver was perfused with 10 ml PBS without Ca 2ϩ and Mg 2ϩ , removed, and cut in small pieces. After digestion with PBS containing 0.1% collagenase, 0.01% hyaluronidase, and 0.002% DNase I (all from Sigma-Aldrich, Steinheim, Germany) for 30 min at 37°C, liver was filtered through a sterile 100-m nylon cell strainer (BD Biosciences) and washed twice with IMDM, and lymphocytes were isolated by Ficoll gradient centrifugation (Ficoll-Paque Plus ; Amersham Biosciences, Uppsala, Sweden).
Immunohistochemistry
Spleen or liver sections (5-7 m) were cut on a cryostat microtome, air dried, fixed in acetone, and blocked with TBS containing 5% mouse serum and the DAKO biotin blocking system (DAKO, Hamburg, Germany). Liver sections were treated additionally with 0.3% H 2 O 2 in PBS to neutralize endogenous peroxidases. Anti-CD8 biotin and anti-B220 biotin (all BD PharMingen) were used as primary mAb, followed by streptavidinconjugated alkaline phosphatase (StreptAB Complex/AP; DAKO) and alkaline phosphatase substrate kit I (Vector Laboratories, Burlingame, CA). For double staining, anti-CD4 FITC (BD PharMingen) was used, followed by rabbit anti-FITC (DAKO), peroxidase-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA), and peroxidase substrate kit 3-amino-9-ethylcarbazole (Vector Laboratories). Staining of apoptotic cells was performed using purified polyclonal rabbit anti-active caspase 3 Abs (BD PharMingen), followed by biotinylated goat anti-rabbit Igs (BD PharMingen), AB complex-HRP (DAKO), and 3-amino-9-ethylcarbazole peroxidase substrate kit (Vector Laboratories). Sections were counterstained with Mayer's hemalum (Calbiochem-Merck).
Serum glutamate dehydrogenase activity
Blood (200 l) taken from the tail vein was collected in serum separator tubes (MICROTAINER brand serum separator tube; BD Biosciences) and centrifuged for 20 min at 3300 ϫ g, and sera were analyzed for glutamate dehydrogenase (GLDH U/L).
Cr release assay
Cytolytic activity of ex vivo isolated spleen cells was tested in a standard 5-h 51 Cr release assay. EL-4 cells coated with the gp33 peptide (KAVYN-FATM) or the control adenovirus E1A 234 -243 peptide (SGPSNTPPEI) at a concentration of 10 Ϫ6 M were used as target cells. The number of P14 T cells in the effector cell population was determined by flow cytometry using TCR V␣2-and V␤8-specific mAb.
Results
Essential role of both IFN-␥ and FasL in P14 T cell-mediated immunopathology
CD8 T cells (10 5 ) from P14 TCR tg mice specific for aa 33-41 (ϭ gp33 epitope) of the LCMV glycoprotein were adoptively transferred into anti-CD40-treated H8 tg mice, ubiquitously expressing the gp33 epitope. One week after T cell transfer, all H8 mice that received wild-type P14 T cells showed severe clinical symptoms, including hunched posture, cachexia, and ataxia (Fig.  1A) . To determine the role of IFN-␥, FasL, and perforin in this model system, P14.IFN-␥°T cells deficient in IFN-␥, P14.gld T cells lacking functional FasL, and perforin-deficient P14.PKO cells were used. The results were strikingly clear-cut. In contrast to wild-type transfers, H8 recipient mice of P14.IFN-␥°or P14.gld T cells exhibited only mild symptoms (slightly ruffled fur), but no cachexia or ataxia. The disease score induced by P14.PKO T cells was reduced only slightly when compared with wild-type P14 T cells.
These data indicated that FasL expressed in activated P14 T cells was involved crucially in the disease process. To provide further evidence for the important role of the Fas pathway, H8 mice deficient in Fas were generated (H8.Fas°). Due to the upregulated FasL expression in Fas-deficient mice (23) (24) (25) , adoptively transferred wild-type P14 T cells were rejected (data not shown). Therefore, Fas-deficient P14 TCR-tg mice (P14. Fas°) were used as a source of Ag-specific T cells. As shown in Fig. 1A , transfer of P14.Fas°T cells into H8 mice induced disease comparable to wild-type P14 T cells, indicating that Fas expression on P14 T cells was not required for pathology. However, transfer of P14.Fas°T cells into H8.Fas°mice failed to induce disease, confirming the data obtained with P14.gld T cells.
To exclude the possibility that the differences in disease severity in the various donor/host combinations were due to different proliferation capacities of the transgenic donor T cells, the frequency of P14 T cells in anti-CD40-treated H8 mice was determined using mAb (V␣2/V␤8) specific for the P14 TCR. As illustrated in Fig.  1B , similar percentages of P14 T cells in host PBL were observed in all donor/host combinations. In all recipients, 80 -95% of total CD8 T cells in spleen and PBL were derived from the small number (10 5 ) of P14 donor T cells injected (data not shown). Taken together, these results demonstrate an essential role of IFN-␥ and of the FasL/Fas pathway in the P14 T cell-induced immunopathological processes in H8 mice.
Similar activation status of wild-type P14, P14.IFN-␥°, P14.gld, and P14.PKO T cells in H8 mice
After transfer into anti-CD40-treated H8 mice, P14 T cells became activated and acquired cytolytic activity (Fig. 2) . The absence of severe pathological effects of P14 T cells lacking IFN-␥ or functional FasL was not due to impaired activation, because wild-type, (Fig. 2A) . Furthermore, the cytolytic activity of P14.IFN-␥°and P14.gld T cells did not differ from wild-type P14 T cells when tested in a standard 51 Cr release assay using gp33 peptide-loaded EL-4 target cells (Fig. 2B) . Similar to wild-type P14 T cells, P14.PKO T cells also exhibited a highly activated phenotype. However, EL-4 target cells were not lysed by these activated P14.PKO T cells. This result is compatible with previous findings that EL-4 target cells are resistant to FasLmediated lysis and can only be lysed by perforin-dependent mechanisms (26, 27) . Taken together, these results demonstrated that, upon transfer in anti-CD40-treated H8 mice, wild-type P14 T cells and P14 T cells lacking IFN-␥, functional FasL, or perforin were activated similarly.
Liver injury by P14 T cells is dependent on IFN-␥, FasL, and perforin
Macroscopic evaluation of livers from anti-CD40-treated H8 mice adoptively transferred with wild-type P14, P14 IFN-␥°, P14.gld T cells, and P14.PKO T cells revealed marked differences. Livers from wild-type P14 T cell transfers were interspersed with necrotic areas, which appeared as white or hemorrhagic spots. In contrast, livers from H8 recipient mice of P14 IFN-␥°, P14.gld, and P14.PKO T cells exhibited no macroscopically visible alterations (Fig. 3A , and data not shown).
To determine the immunopathological effects of P14 T cells in H8 mice quantitatively, GLDH levels in the sera were determined. GLDH is an enzyme that can be found in all organs, preferentially in the mitochondria of liver cells, and is typically elevated in the sera after liver cell damage. As shown in Fig. 3B , H8 recipient mice of wild-type or Fas-deficient P14 T cells had high serum levels of GLDH. In contrast, GLDH levels were decreased significantly in H8 mice transferred with P14 IFN-␥°, P14.gld, or P14.PKO T cells, or in Fas-deficient H8.Fas°mice that had received Fas-deficient P14 T cells. Similar results were obtained when the number of the transferred wild-type P14 T cells was lowered 10-fold (10 4 per H8 mouse) and the number of P14.gld T cells was increased 10-fold (10 6 per H8 mouse) (Fig. 3C ). Caspase-3 has been implicated as a key protease that is activated during the signaling pathway of apoptosis. Immunohistological analysis of liver sections from H8 mice that had received wild-type P14 T cells revealed a high number of caspase 3-expressing cells, localized mainly around the necrotic areas (Fig. 4B) . In contrast, only a few positive cells were found in liver sections of H8 mice that had been transferred with P14.IFN-␥°or P14.gld T cells (Fig.  4, C and D) . Similarly, caspase 3-positive cells were almost undetectable in Fas-deficient H8 mice after transfer of P14.Fas°T cells (data not shown) or in H8 control mice treated only with anti-CD40 mAb (Fig. 4A) . Quantitative analysis of infiltrating P14 T cells indicated that the reduced hepatocyte damage in the absence of donor T cell-derived IFN-␥, FasL/Fas interaction, or perforin was not due to impaired liver infiltration of the P14.IFN-␥°, P14.gld, and P14.PKO T cells (Fig. 4, I and J) . with anti-CD40 mAb only. Moreover, Fas up-regulation on hepatocytes was significantly higher after transfer with wild-type compared with P14.IFN-␥°T cells (Fig. 5A ). Besides the difference in Fas up-regulation on hepatocytes, we also observed a 2-fold decrease in FasL expression of P14.IFN-␥°splenocytes compared with wild-type P14 T cells (Fig. 5B) . Similarly, P14 T cells infiltrating into the H8 mouse liver also expressed higher levels of FasL than P14.IFN-␥° (Fig. 5C ). Taken together, these results indicated that IFN-␥ released by activated P14 T cells promotes FasL-mediated destruction of hepatocytes by increasing Fas expression on target cells and FasL expression on attacking CTL.
IFN-␥ up-regulates Fas expression in hepatocytes and FasL expression in P14 T cells
IFN-␥ is known to increase
Destruction of the splenic architecture by P14 T cells is independent of IFN-␥, FasL, and perforin
Expansion of P14 T cells in anti-CD40-treated H8 mice was accompanied by a severe loss of host lymphocytes and destruction of (10 5 ) into anti-CD40-treated H8 mice, mice were sacrificed and livers were photographed. B, GLDH levels in the sera of the indicated groups of mice were determined 1 wk after P14 T cell (10 5 ) transfer. C, P14 (10 4 ) and P14.gld (10 6 ) T cells were transferred into H8 mice. Seven days after transfer and anti-CD40 treatment, the percentage of P14 ϩ T cells in PBL and the GLDH level in the sera of the recipient mice were determined. Dots indicate individual mice.
FIGURE 4.
Differences in induction of caspase 3 in hepatocytes despite comparable liver infiltration by CD8 T cells. H8 recipient mice were injected with 10 5 P14 T cells from the indicated donor mice and treated with anti-CD40 mAb. After 1 wk, mice were sacrificed. A-H, Frozen sections of liver were stained with anti-caspase 3 Abs (A-D) and anti-CD8 mAb (E-H). The P14 TCR (V␣2/V␤8) was expressed on 80 -95% of the CD8 T cells from the mice analyzed (data not shown). I-J, Absolute cell numbers of total hepatic (I) and P14 ϩ hepatic (J) lymphocytes were determined by flow cytometry following isolation, as described in Materials and Methods. the splenic architecture. The few remaining CD4 T cells manifested a diffuse localization, and the size of B cell follicles was reduced strongly compared with anti-CD40-treated control mice. In contrast to the important role of IFN-␥, FasL, and perforin in liver cell damage, destruction of the splenic architecture by P14 T cells occurred in the absence of IFN-␥, FasL (Fig. 6 ), or perforin (data not shown). Thus, the effector mechanisms that caused immunopathology in the liver appeared to be redundant for immunopathological destruction and depletion of host lymphocytes in the spleen.
Discussion
The effector molecules involved in T cell-mediated hepatitis have been studied by several groups using different systems. Liver damage induced by injection of Con A into mice (31) has been shown to be mediated by a distinct NK1.1-expressing T cell subset, termed V␣14 NK T cells, which is required and sufficient for development of hepatitis (32) . In Con A-induced hepatitis, perforin (32, 33) , FasL (32, 34, 35), IFN-␥ (36, 37) , and TNF (38 -40) have all been reported to play key roles as effector molecules in T cellmediated hepatocyte injury. Besides differences in mouse strains and experimental protocols, these partly conflicting results could be due to the complexity of this model system, because Con A treatment is likely to cause multiple effects on the immune system in vivo.
In the model described in this work, monoclonal CD8 T cells with defined Ag specificity were used. The results revealed important roles of IFN-␥, FasL, and perforin as mediators of CTLinduced liver cell injury in vivo. A nonredundant function of FasL has been reported previously by Kondo et al. (41) , using an adoptive transfer system with a hepatitis B virus surface Ag (HBsAg)-specific CTL clone and HBsAg-tg mice. However, this finding could not be confirmed by Chisari and colleagues (42) , although the same CTL clone and the same hepatitis B virus-tg mouse line were used. In the model described by Kennedy et al. (43) , injection of soluble OVA peptide into OT-1 TCR-tg mice specific for OVA led to hepatocyte damage and increase in transaminase levels in the sera. As in our system, Fas expression on hepatocytes was required for disease, but the role of IFN-␥, FasL, and perforin was not examined.
How can the dramatic effect of IFN-␥ on CTL-mediated liver damage be rationalized? IFN-␥ is known to up-regulate Fas expression in various tumor cell lines, liver macrophages, and parenchymal cells in vitro (28 -30) . In vivo, ectopic expression of IFN-␥ in the liver of tg mice has been shown to increase Fas at the mRNA level (44) . Moreover, IFN-␥ produced by activated CD8 T cells in an acute graft-vs-host disease model has been reported to increase Fas expression on host lymphocytes (45) . In the liver, up-regulation of Fas mRNA expression by Con A treatment was reduced to 50% in IFN-␥-deficient mice when compared with IFN-␥ ϩ/Ϫ mice (37) . At the functional level, Ag-dependent release of IFN-␥ by activated CTL has recently been demonstrated to facilitate target cell lysis in vitro (46) . Our results demonstrate that Fas expression on hepatocytes was increased after transfer with wildtype compared with IFN-␥-deficient P14 T cells. This suggests that IFN-␥ released by activated P14 T cells upon Ag contact up-regulates Fas expression on hepatocytes, making them more susceptible for FasL-mediated T cell attack. Besides the difference in Fas expression on hepatocytes, we also observed higher levels of FasL ϩ splenic (B), and CD8 ϩ hepatic lymphocytes (C) were analyzed by flow cytometry using mAb specific for Fas or FasL, as described in Materials and Methods. The P14 TCR (V␣2/V␤8) was expressed on 80 -95% of the CD8 T cells from the mice analyzed (data not shown). Isotype controls are shown as filled histograms. Numbers indicate mean fluorescence intensities of the histograms. (47) and that are thought to be involved in the transcriptional control of the FasL gene (48, 49) .
GLDH levels in H8 recipient mice of P14.gld and P14.PKO T cells were reduced similarly, indicating that both FasL-and perforin-dependent signals were involved in hepatocyte damage by P14 T cells. This result fits well with previous data in the HBsAg-tg system using CTL clones from gld/gld and PKO mice (42) . In this context, IFN-␥ produced by activated P14 T cells may enhance MHC class I expression on hepatocytes that might facilitate perforin-mediated lysis in vivo. In addition, IFN-␥ has been shown to induce genes involved in signaling of cell death (35, 50, 51) or to down-regulate antiapoptotic molecules (52) . An indispensable role for TNF and IFN-␥ in liver injury mediated by HBsAg-specific CD4 T cells has been reported recently by Ohta et al. (53) . In contrast to our data with CD8 T cells, FasL was not essential in this Th1-mediated model of liver injury. Thus, IFN-␥ may also exert direct cytotoxic effects on hepatocytes in vivo, as has been suggested by in vitro data (54) . In addition, inducible NO synthase induced by IFN-␥ and TNF may participate in the liver cytotoxicity of this cytokine (55) .
Five to 7 days after T cell transfer, H8 mice that received P14.PKO T cells developed only slightly reduced signs of illness (cachexia, ataxia, hunched posture, moribund) compared with wild-type P14 T cells, although serum GLDH levels were significantly lowered in P14.PKO transfers. This may indicate that P14 T cell-mediated immunopathology in organs other than the liver contributed to the clinical symptoms observed. In this context, it is noteworthy that massive infiltration of donor P14 T cells was also found in lung and bone marrow, but not in brain of the recipient mice. In contrast to classical graft-vs-host reactions induced by transfer of allogeneic T cells into irradiated recipient mice, allopecia or ulceration of the skin was not observed in H8 mice after P14 T cell transfer (data not shown).
In conclusion, we have used a transfer model with TCR-tg and Ag-tg mice to analyze the mechanism of liver cell damage by CTLs in vivo. The results revealed a crucial role of IFN-␥, FasL, and perforin in liver cell destruction. It is important to stress that these effector molecules were not essential for destruction of the splenic architecture and depletion of host lymphocytes by P14 T cells in the same model. This indicates that the effector molecules required for target cell destruction in vivo could vary with the cell type (i.e., hepatocytes vs lymphocytes) attacked by CTLs.
